These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 9435909)

  • 1. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.
    Müller CE; Geis U; Hipp J; Schobert U; Frobenius W; Pawłowski M; Suzuki F; Sandoval-Ramírez J
    J Med Chem; 1997 Dec; 40(26):4396-405. PubMed ID: 9435909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists.
    Poulsen SA; Quinn RJ
    J Med Chem; 1996 Oct; 39(21):4156-61. PubMed ID: 8863792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA
    J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
    J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
    Müller CE; Geis U; Grahner B; Lanzner W; Eger K
    J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo analysis of receptor binding affinity data of 8-ethenyl-xanthine antagonists to adenosine A1 and A2a receptors.
    Dalpiaz A; Gessi S; Varani K; Borea PA
    Arzneimittelforschung; 1997 May; 47(5):591-4. PubMed ID: 9205770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of iodinated and brominated [11C]styrylxanthine derivatives as in vivo radioligands mapping adenosine A2A receptor in the central nervous system.
    Ishiwata K; Shimada J; Wang WF; Harakawa H; Ishii S; Kiyosawa M; Suzuki F; Senda M
    Ann Nucl Med; 2000 Aug; 14(4):247-53. PubMed ID: 11023024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors.
    Vittori S; Camaioni E; Di Francesco E; Volpini R; Monopoli A; Dionisotti S; Ongini E; Cristalli G
    J Med Chem; 1996 Oct; 39(21):4211-7. PubMed ID: 8863798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacology of pyrido[2,3-d]pyrimidinediones bearing polar substituents as adenosine receptor antagonists.
    Bulicz J; Bertarelli DC; Baumert D; Fülle F; Müller CE; Heber D
    Bioorg Med Chem; 2006 Apr; 14(8):2837-49. PubMed ID: 16377196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of two affinity states of adenosine A2a receptors with a new radioligand, 2-[2-(4-amino-3-[125I]iodophenyl)ethylamino]adenosine.
    Luthin DR; Olsson RA; Thompson RD; Sawmiller DR; Linden J
    Mol Pharmacol; 1995 Feb; 47(2):307-13. PubMed ID: 7870039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and preliminary evaluation of new 1- and 3-[1-(2-hydroxy-3-phenoxypropyl)]xanthines from 2-amino-2-oxazolines as potential A1 and A2A adenosine receptor antagonists.
    Massip S; Guillon J; Bertarelli D; Bosc JJ; Léger JM; Lacher S; Bontemps C; Dupont T; Müller CE; Jarry C
    Bioorg Med Chem; 2006 Apr; 14(8):2697-719. PubMed ID: 16386423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.
    Yan L; Müller CE
    J Med Chem; 2004 Feb; 47(4):1031-43. PubMed ID: 14761205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
    Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
    Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 3-aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5-d]pyrimidines with high affinity toward A1 adenosine receptors.
    Betti L; Biagi G; Giannaccini G; Giorgi I; Livi O; Lucacchini A; Manera C; Scartoni V
    J Med Chem; 1998 Feb; 41(5):668-73. PubMed ID: 9513594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-substituted 1,8-naphthyridines and pyrido[2,3-d]pyrimidines: new compounds with affinity for A1- and A2-adenosine receptors.
    Müller CE; Grahner B; Heber D
    Pharmazie; 1994 Dec; 49(12):878-80. PubMed ID: 7838877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor.
    van der Wenden EM; Carnielli M; Roelen HC; Lorenzen A; von Frijtag Drabbe Künzel JK; IJzerman AP
    J Med Chem; 1998 Jan; 41(1):102-8. PubMed ID: 9438026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological evaluation of novel 1,3,8- and 1,3,7,8-substituted xanthines as adenosine receptor antagonists.
    Rodríguez-Borges JE; García-Mera X; Balo MC; Brea J; Caamaño O; Fernández F; López C; Loza MI; Nieto MI
    Bioorg Med Chem; 2010 Mar; 18(5):2001-9. PubMed ID: 20137957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives.
    van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; IJzerman AP
    J Med Chem; 1998 Oct; 41(21):3987-93. PubMed ID: 9767636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists.
    Yang M; Soohoo D; Soelaiman S; Kalla R; Zablocki J; Chu N; Leung K; Yao L; Diamond I; Belardinelli L; Shryock JC
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):133-44. PubMed ID: 17310264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.